Cytokinetics Inc (CYTK)-Financial and Strategic SWOT Analysis Review

Cytokinetics Inc (CYTK)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH66590FSA
  • |
  • Pages: 59
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cytokinetics Inc (CYTK)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases, which compromise muscle performance. The company's lead drug candidate, tirasemtiv, a fast skeletal muscle troponin activator, is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis (ALS). Its lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is in Phase III clinical trials for heart failure. Its other pipeline products include CK-2127107 for the treatment spinal muscular atrophy and chronic obstructive pulmonary disease. It has licensing agreements with Amgen and Astellas for the development of its drug candidates. Cytokinetics is headquartered in South San Francisco, California, the US.

Cytokinetics Inc Key Recent Developments

Apr 27,2017: Cytokinetics Reports First Quarter 2017 Financial Results

Feb 16,2017: Cytokinetics Reports Fourth Quarter 2016 Financial Results

Oct 27,2016: Cytokinetics Reports Third Quarter 2016 Financial Results

Sep 08,2016: Cytokinetics Announces Next-Generation Fast Skeletal Muscle Activator Entering IND-Enabling Studies

Jul 28,2016: Cytokinetics Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Cytokinetics Inc-Key Facts 6

Cytokinetics Inc-Key Employees 7

Cytokinetics Inc-Key Employee Biographies 8

Cytokinetics Inc-Major Products and Services 9

Cytokinetics Inc-Pharmaceutical Pipeline Products Data 10

Cytokinetics Inc, Pipeline Products by Therapy Area 10

Cytokinetics Inc, Pipeline Products by Development Phase 11

Cytokinetics Inc-History 12

Cytokinetics Inc-Company Statement 15

Cytokinetics Inc-Locations And Subsidiaries 19

Head Office 19

Section 2-Company Analysis 20

Cytokinetics Inc-Business Description 20

Cytokinetics Inc-Corporate Strategy 21

Cytokinetics Inc-SWOT Analysis 22

SWOT Analysis-Overview 22

Cytokinetics Inc-Strengths 22

Cytokinetics Inc-Weaknesses 23

Cytokinetics Inc-Opportunities 24

Cytokinetics Inc-Threats 25

Cytokinetics Inc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 33

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 34

Cytokinetics Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Apr 27, 2017: Cytokinetics Reports First Quarter 2017 Financial Results 36

Feb 16, 2017: Cytokinetics Reports Fourth Quarter 2016 Financial Results 38

Oct 27, 2016: Cytokinetics Reports Third Quarter 2016 Financial Results 41

Sep 08, 2016: Cytokinetics Announces Next-Generation Fast Skeletal Muscle Activator Entering IND-Enabling Studies 44

Jul 28, 2016: Cytokinetics Reports Second Quarter 2016 Financial Results 45

Jul 27, 2016: Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS 47

May 20, 2016: Cytokinetics Appoints Edward M. Kaye, M.D., to Board of Directors 48

Apr 28, 2016: Cytokinetics Reports First Quarter 2016 Financial Results 49

Feb 16, 2016: Cytokinetics Reports Fourth Quarter 2015 Financial Results 51

Jan 11, 2016: Cytokinetics Outlines Vision 2020 Strategic Initiative to Advance Portfolio of Muscle Biology Drug Candidates 54

Section 6-Appendix 55

Methodology 55

Ratio Definitions 55

About GlobalData 59

Contact Us 59

Disclaimer 59

List of Figures

Cytokinetics Inc, Pipeline Products by Therapy Area 10

Cytokinetics Inc, Pipeline Products by Development Phase 11

Cytokinetics Inc, Performance Chart (2012-2016) 30

Cytokinetics Inc, Ratio Charts 32

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 33

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 34

List of Tables

Cytokinetics Inc, Key Facts 6

Cytokinetics Inc, Key Employees 7

Cytokinetics Inc, Key Employee Biographies 8

Cytokinetics Inc, Major Products and Services 9

Cytokinetics Inc, Number of Pipeline Products by Therapy Area 10

Cytokinetics Inc, Number of Pipeline Products by Development Stage 11

Cytokinetics Inc, History 12

Cytokinetics Inc, Key Competitors 26

Cytokinetics Inc, Ratios based on current share price 27

Cytokinetics Inc, Annual Ratios 28

Cytokinetics Inc, Annual Ratios (Cont...1) 29

Cytokinetics Inc, Interim Ratios 31

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 33

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 34

Cytokinetics Inc, Recent Deals Summary 35

Currency Codes 55

Capital Market Ratios 55

Equity Ratios 56

Profitability Ratios 56

Cost Ratios 57

Liquidity Ratios 57

Leverage Ratios 58

Efficiency Ratios 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cytokinetics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8060
Site License
USD 250 INR 16120
Corporate User License
USD 375 INR 24180

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com